Aortic aneurysms: current pathogenesis and therapeutic targets

被引:15
|
作者
Cho, Min Ji [1 ]
Lee, Mi-Ran [2 ]
Park, Jong-Gil [1 ,3 ]
机构
[1] Korea Res Inst Biosci & Biotechnol KRIBB, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea
[2] Jungwon Univ, Dept Biomed Lab Sci, 85 Munmu Ro, Chungbuk 28024, South Korea
[3] Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Biosci, 125 Gwahak Ro, Daejeon 34141, South Korea
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2023年 / 55卷 / 12期
基金
新加坡国家研究基金会;
关键词
PERIARTERIAL APPLICATION; OXIDATIVE STRESS; INTERFERON-GAMMA; MARFAN-SYNDROME; MUTATIONS; DISSECTIONS; ACTIVATION; EXPRESSION; PROTEIN; ANGIOGENESIS;
D O I
10.1038/s12276-023-01130-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aortic aneurysm is a chronic disease characterized by localized expansion of the aorta, including the ascending aorta, arch, descending aorta, and abdominal aorta. Although aortic aneurysms are generally asymptomatic, they can threaten human health by sudden death due to aortic rupture. Aortic aneurysms are estimated to lead to 150,000 similar to 200,000 deaths per year worldwide. Currently, there are no effective drugs to prevent the growth or rupture of aortic aneurysms; surgical repair or endovascular repair is the only option for treating this condition. The pathogenic mechanisms and therapeutic targets for aortic aneurysms have been examined over the past decade; however, there are unknown pathogenic mechanisms involved in cellular heterogeneity and plasticity, the complexity of the transforming growth factor-beta signaling pathway, inflammation, cell death, intramural neovascularization, and intercellular communication. This review summarizes the latest research findings and current pathogenic mechanisms of aortic aneurysms, which may enhance our understanding of aortic aneurysms.
引用
下载
收藏
页码:2596 / 2607
页数:12
相关论文
共 50 条
  • [41] Pathogenesis, emerging therapeutic targets and treatment in sialidosis
    D'Azzo, Alessandra
    Machado, Eda
    Annunziata, Ida
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (05): : 491 - 504
  • [42] Pathogenesis and New Therapeutic Targets of Ovarian Cancer
    Shih, Ie-Ming
    Ho, Chih-Ming
    Nakayama, Kentaro
    Salani, Ritu
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [43] Molecular pathogenesis and therapeutic targets of lysosomal diseases
    Tsuji, Daisuke
    Itoh, Kohji
    SEIKAGAKU, 2007, 79 (07): : 678 - 682
  • [44] Current strategy of endovascular aortic repair for thoracic aortic aneurysms
    Kuratani T.
    Sawa Y.
    General Thoracic and Cardiovascular Surgery, 2010, 58 (8) : 393 - 398
  • [45] Vascular Macrophages as Therapeutic Targets to Treat Intracranial Aneurysms
    Muhammad, Sajjad
    Chaudhry, Shafqat Rasul
    Dobreva, Gergana
    Lawton, Michael T.
    Niemela, Mika
    Hanggi, Daniel
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] The key role of miRNA in syndromic and sporadic forms of ascending aortic aneurysms as biomarkers and targets of novel therapeutic strategies
    Terriaca, Sonia
    Monastero, Roberto
    Orlandi, Augusto
    Balistreri, Carmela Rita
    FRONTIERS IN GENETICS, 2024, 15
  • [47] Current therapy of ruptured abdominal aortic aneurysms
    Kopp, R.
    Hekeler, O.
    Gumpinger, F.
    Peckelsen, C.
    Gogarten, W.
    NOTFALL & RETTUNGSMEDIZIN, 2009, 12 (07): : 493 - 501
  • [48] Oxidative Stress in the Pathogenesis of Aorta Diseases as a Source of Potential Biomarkers and Therapeutic Targets, with a Particular Focus on Ascending Aorta Aneurysms
    Pisano, Calogera
    Benedetto, Umberto
    Ruvolo, Giovanni
    Balistreri, Carmela Rita
    ANTIOXIDANTS, 2022, 11 (02)
  • [49] Current management of infrarenal abdominal aortic aneurysms
    Ellason, Jonathan L.
    Clouse, W. Darrin
    SURGICAL CLINICS OF NORTH AMERICA, 2007, 87 (05) : 1017 - +
  • [50] Current treatment options for ruptured aortic aneurysms
    Kouvelos, G.
    Katsargyris, A.
    Toepel, I.
    Steinbauer, M.
    Verhoeven, E. L. G.
    NOTFALL & RETTUNGSMEDIZIN, 2017, 20 (04): : 283 - 291